- Home
- PSNL vs SENS Comparison
PSNL vs SENS Comparison
Compare PSNL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- SENS
- Stock Information
- Founded
- PSNL 2011
- SENS 1996
- Country
- PSNL United States
- SENS United States
- Employees
- PSNL N/A
- SENS N/A
- Industry
- PSNL Medical Specialities
- SENS Industrial Machinery/Components
- Sector
- PSNL Health Care
- SENS Industrials
- Exchange
- PSNL Nasdaq
- SENS Nasdaq
- Market Cap
- PSNL 460.7M
- SENS 396.0M
- IPO Year
- PSNL 2019
- SENS N/A
- Fundamental
- Price
- PSNL $4.63
- SENS $0.52
- Analyst Decision
- PSNL Strong Buy
- SENS Strong Buy
- Analyst Count
- PSNL 5
- SENS 2
- Target Price
- PSNL $8.00
- SENS $2.00
- AVG Volume (30 Days)
- PSNL 742.2K
- SENS 6.9M
- Earning Date
- PSNL 05-06-2025
- SENS 05-08-2025
- Dividend Yield
- PSNL N/A
- SENS N/A
- EPS Growth
- PSNL N/A
- SENS N/A
- EPS
- PSNL N/A
- SENS N/A
- Revenue
- PSNL $85,694,000.00
- SENS $23,682,000.00
- Revenue This Year
- PSNL $1.16
- SENS $60.14
- Revenue Next Year
- PSNL $25.58
- SENS $36.55
- P/E Ratio
- PSNL N/A
- SENS N/A
- Revenue Growth
- PSNL 15.57
- SENS 1.64
- 52 Week Low
- PSNL $1.14
- SENS $0.25
- 52 Week High
- PSNL $7.20
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- PSNL 53.76
- SENS 39.02
- Support Level
- PSNL $4.44
- SENS $0.52
- Resistance Level
- PSNL $5.06
- SENS $0.54
- Average True Range (ATR)
- PSNL 0.30
- SENS 0.04
- MACD
- PSNL -0.07
- SENS -0.00
- Stochastic Oscillator
- PSNL 19.83
- SENS 16.29
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.